Dzuba Ilana G, Díaz Elsa Yunes, Allen Betania, Leonard Yvonne Flores, Lazcano Ponce Eduardo C, Shah Keerti V, Bishai David, Lorincz Attila, Ferris Daron, Turnbull Bernardo, Hernández Avila Mauricio, Salmerón Jorge
The Johns Hopkins University School of Public Health, Baltimore, Maryland, USA.
J Womens Health Gend Based Med. 2002 Apr;11(3):265-75. doi: 10.1089/152460902753668466.
To explore the acceptability of the self-collection of samples for human papillomavirus (HPV) testing in comparison with that of the Pap test.
The study population consisted of 1069 women 20 years and older who were eligible for coverage through the Mexican Institute of Social Security (IMSS). These women were randomly selected among participants in a larger study to evaluate the use of HPV testing as an alternative in cervical cancer screening. All participants provided a self-collected vaginal sample for HPV testing according to explicit instructions and underwent a Pap test. Afterwards, each woman was interviewed about her experience and opinion regarding the two procedures. Acceptability was measured by a calculated score based on discomfort, pain, embarrassment, privacy, perception of personal treatment during the Pap test, and understanding of how to perform the self-sampling method.
Ninety-three percent of women experienced sufficient privacy with the Pap test, whereas 98% of women reported that privacy with the self-sampling procedure was acceptable. The Pap test consistently provoked more discomfort, pain, and embarrassment than self-sampling. Sixty-eight percent of the women who indicated a test preference chose self-sampling. Preference for this method was positively associated with monthly household income. Women reported a preference for self-sampling because it is more comfortable (71.2%) and causes less embarrassment (55.8%).
Self-sampling is more acceptable than the Pap test and could improve coverage rates of early detection programs. The incorporation of self-collected samples to detect HPV could encourage participation in screening programs among those women who reject the Pap test because of the necessary pelvic examination.
探讨人乳头瘤病毒(HPV)检测样本自我采集与巴氏试验相比的可接受性。
研究人群包括1069名20岁及以上符合墨西哥社会保障局(IMSS)覆盖条件的女性。这些女性是在一项更大规模研究的参与者中随机选取的,该研究旨在评估HPV检测作为宫颈癌筛查替代方法的应用。所有参与者均按照明确指示自行采集阴道样本进行HPV检测,并接受巴氏试验。之后,对每位女性就其对这两种检查程序的体验和看法进行访谈。可接受性通过基于不适、疼痛、尴尬、隐私、巴氏试验期间对个人治疗的感受以及对如何进行自我采样方法的理解计算得出的分数来衡量。
93%的女性认为巴氏试验有足够的隐私性,而98%的女性表示自我采样程序的隐私性是可接受的。与自我采样相比,巴氏试验始终会引发更多的不适、疼痛和尴尬。68%表示有检查偏好的女性选择了自我采样。对这种方法的偏好与家庭月收入呈正相关。女性表示更喜欢自我采样,因为它更舒适(71.2%)且尴尬程度更低(55.8%)。
自我采样比巴氏试验更易被接受,并且可以提高早期检测项目的覆盖率。纳入自我采集的样本以检测HPV可以鼓励那些因必要的盆腔检查而拒绝巴氏试验的女性参与筛查项目。